Levels of a protein believed to be a main cause of Alzheimer's disease rose in the blood of patients treated with Eli Lilly's experimental drug in late-stage trials, suggesting the protein, beta amyloid, was removed from the brain as intended
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment